Twist Bioscience

清水厚志

岩手医科大学医歯薬総合研究所生体情報解析部門教授

同いわて東北メディカル・メガバンク機構副機構長、生体情報解析部門部門長; 同ゲノムオミックス解析支援センターセンター長

青山学院大学にて化学を専攻し、金属タンパク質の電子軌道についての研究で博士号を取得した。学位取得後、故清水信義教授が運営する慶應義塾大学医学部分子生物学教室にて博士研究員として従事し、ヒトゲノム計画に情報解析担当として参加。その後、次世代型シークエンサーを用いた疾患ゲノム解析などバイオインフォマティクスを専門とし、教育用の図書などを執筆。現在は岩手医科大学の教授として、またいわて東北メディカル・メガバンク機構副機構長としてゲノムコホート研究である東北メディカル・メガバンク計画を推進し、個別化予防の実現を目指している。
現在の専門はゲノム医学、特に疾患ゲノム解析とエピジェネティクス

Enter Presenter 2 Header

Enter Presenter 2 Name

Enter Presenter 2 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 3 Header

Enter Presenter 3 Name

Enter Presenter 3 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 4 Header

Enter Presenter 4 Name

Enter Presenter 4 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 5 Header

Enter Presenter 5 Name

Enter Presenter 5 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 6 Header

Enter Presenter 6 Name

Enter Presenter 6 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

第16回日本エピジェネティクス研究会年会

日付と時刻

イントロダクション

Enter Details Header

清水厚志

Enter Presenter 2 Header

Enter Presenter 3 Header

Enter Presenter 4 Header

Enter Presenter 5 Header

Enter Presenter 6 Header